Awards & Recognition

Company of the Year

2009 Frost & Sullivan Drug Discovery Technologies Company of the Year

Frost and Sullivan AwardFrost & Sullivan recognizes Life Technologies with the 2009 North American Frost & Sullivan Company of the Year Award. The company’s size, product portfolio breadth, market segment leadership, and strong future potential set it apart from any competitor in the life science research tools industry. Moreover, Life Technologies shows great commitment to providing innovative and enabling tools across the life science research continuum.

More Awards & Recognition

* 2009 - Newsweek Magazine - Life Technologies listed among America's 500 largest green corporations
* 2009 - Frost & Sullivan Drug Discovery Technologies Company of the Year
* 2009 - Frost & Sullivan Drug Discovery Technologies CEO of the Year
* 2009 - BBBOnLine Accreditation
* 2008 - TIME Magazine - SPOT-Light HER2 CISH Kit named in Top 10 Medical Breakthroughs
* 2008 - The Scientist - SOLiD Named Top Innovation of 2008
* 2008 - Connect - Most Innovative Product Finalist, StemPro BG01v platform cell engineering kit
* 2008 - San Diego Urban League, Urban Legacy Award for Environmentalism and Sustainability
* 2008 - APEX Award of Excellence, Print Publications, 32+ pages - Invitrogen's Quest (Vol. 4, Issue 2)
* 2008 - APEX Award of Excellence, Design & Layout - BioProbes 55 Magazine
* 2008 - Life Science Industry Awards - Cell Biology Kits and Reagents
* 2008 - Life Science Industry Awards - Cell Culture Media and Reagents
* 2008 - Life Science Industry Awards - Most Responsive Customer Service
* 2008 - Life Science Industry Awards - Most Knowledgeable Technical Support
* 2008 - Life Science Industry Awards - Most Useful Website

News

  • TGen Study

    LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. The goal of this first-of-its-kind research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.

    Read All Close
  • SMS Technology

    Life Technologies Corporation announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

    Read All Close
  • SOLiD PI ANNOUNCED

    Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    Read All Close

Life (Common Stock)

Sustainability Indexes

The former Invitrogen Corporation was selected as a new member of the Dow Jones Sustainability World Index (DJSI World) and named leader of the biotechnology sector for 2008. The company ranked in the top 10% of the world's 2,500 largest companies in terms of sustainability for performance in corporate governance, labor practices, talent development, community involvement, workplace safety, climate change, and environmental management. Life Technologies was named to the FTSE4Good Index Series, an equity index series that facilitates investment in companies that meet globally recognized citizenship standards, in March 2009.